{
  "issues": [
    {
      "code": "INAPPROPRIATE_PROTOCOL_SELECTION",
      "description": "Agent 2 included the low‑dose CT lung‑cancer screening protocol (CT_CHEST_LOW_DOSE_SCREENING) as a potential option, but this protocol does not evaluate pulmonary embolism and is unsuitable for the patient’s acute presentation."
    },
    {
      "code": "INCOMPLETE_LAB_METADATA",
      "description": "Renal tool flagged missing BMI and absent timestamps for laboratory values, reducing the reliability of risk stratification."
    },
    {
      "code": "POTENTIAL_OVERHYDRATION",
      "description": "Recommendation to aggressive pre‑hydration with isotonic saline may be unsafe given the patient’s hypotension (MAP 57 mmHg) and possible volume overload from CKD and heart disease. Fluid status must be assessed before any large‑volume hydration."
    },
    {
      "code": "HYPERKALAEMIA_NOT_ADDRESSED_PRIOR_TO_CONTRAST",
      "description": "Critical hyperkalemia (K⁺ 5.8 mmol/L) must be corrected before any iodinated contrast administration; the current recommendations mention prioritization but do not specify concrete management steps."
    },
    {
      "code": "RENAL_RISK_UNDEREMPHASIZED",
      "description": "eGFR 22 mL/min/1.73 m² places the patient at high risk for contrast‑induced nephropathy; the protocol suggestions lack explicit post‑contrast renal monitoring and use of iso‑osmolar contrast agents."
    },
    {
      "code": "ALTERNATIVE_MODALITY_NOT_EVALUATED",
      "description": "Potential use of non‑contrast MR pulmonary angiography or nuclear medicine ventilation‑perfusion scan availability was not discussed, although these could be safer alternatives."
    }
  ],
  "recommendations": [
    {
      "action": "Imaging modality selection",
      "detail": "Prioritize a ventilation‑perfusion (V/Q) scan as the first‑line test for suspected PE given severe CKD and hemodynamic instability. If V/Q is unavailable or non‑diagnostic, proceed to bedside transthoracic echocardiography to assess right‑heart strain."
    },
    {
      "action": "Exclude inappropriate protocol",
      "detail": "Remove the low‑dose CT lung‑cancer screening protocol from consideration for this acute PE work‑up."
    },
    {
      "action": "Hyperkalemia management",
      "detail": "Initiate urgent potassium‑lowering therapy (e.g., IV calcium gluconate, insulin‑glucose, nebulized albuterol, sodium polystyrene sulfonate) and re‑check serum K⁺ before any contrast study."
    },
    {
      "action": "Fluid assessment before hydration",
      "detail": "Perform bedside assessment of volume status (e.g., ultrasound IVC, bedside echo, physical exam). If the patient is hypovolemic, give cautious isotonic saline (e.g., 250 mL bolus) with close hemodynamic monitoring; avoid aggressive large‑volume hydration in the setting of hypotension or possible heart failure."
    },
    {
      "action": "Contrast‑enhanced CT considerations",
      "detail": "If CTPA becomes unavoidable, use iso‑osmolar, low‑iodine‑concentration contrast (e.g., iodixanol) at the minimal effective volume (≈80 mL). Apply a pre‑ and post‑procedure renal protection protocol: N‑acetylcysteine or sodium bicarbonate infusion, strict fluid balance, and repeat serum creatinine at 24‑48 h."
    },
    {
      "action": "Post‑contrast renal monitoring",
      "detail": "Schedule serum creatinine and eGFR checks at 24 h and 48 h after contrast exposure; have nephrology consultation ready if renal function deteriorates."
    },
    {
      "action": "Data completeness improvement",
      "detail": "Record patient BMI and include timestamps for all laboratory values in the EMR to improve future renal tool accuracy."
    },
    {
      "action": "Alternative non‑iodinated imaging",
      "detail": "Evaluate the feasibility of a non‑contrast MR pulmonary angiography or a nuclear medicine V/Q scan (if available) as alternatives to iodinated contrast."
    },
    {
      "action": "Documentation",
      "detail": "Document the rationale for selecting or rejecting each imaging protocol in the radiology order set, explicitly noting renal risk, hemodynamic status, and hyperkalemia management."
    }
  ],
  "confidence": 0.86,
  "agent2_confidence": 0.66,
  "timestamp": "2025-09-08T05:34:43.925876Z",
  "tool_outputs": {
    "renal": {
      "tool_id": "renal_tool_v2",
      "checks": [
        {
          "id": "egfr_ckd_epi",
          "units": "ml/min/1.73m2",
          "timestamp": "2025-09-08T05:34:29.792431Z",
          "priority": "critical",
          "value": 22.0,
          "status": "fail",
          "reason": "High renal risk; contrast caution."
        },
        {
          "id": "creatinine_mg_dl",
          "units": "mg/dL",
          "timestamp": "2025-09-08T05:34:29.792439Z",
          "priority": "critical",
          "value": 3.2,
          "status": "fail",
          "reason": "Creatinine significantly elevated."
        },
        {
          "id": "bun_creatinine_ratio",
          "timestamp": "2025-09-08T05:34:29.792443Z",
          "priority": "important",
          "value": 20.3,
          "status": "warning",
          "reason": "BUN/Cr ratio suggests prerenal azotemia."
        },
        {
          "id": "potassium_mmol_l",
          "units": "mEq/L",
          "timestamp": "2025-09-08T05:34:29.792449Z",
          "priority": "important",
          "value": 5.8,
          "status": "fail",
          "reason": "Critical hyperkalemia."
        }
      ],
      "summary": {
        "overall": "fail",
        "reasons": [
          "High renal risk; contrast caution.",
          "Creatinine significantly elevated.",
          "BUN/Cr ratio suggests prerenal azotemia.",
          "Critical hyperkalemia.",
          "Missing BMI or creatinine.",
          "No lab timestamps provided."
        ],
        "confidence": 0.52
      },
      "metadata": {
        "version": "2.0.0",
        "run_ts": "2025-09-08T05:34:29.792477Z"
      }
    }
  },
  "llm_raw": "{\n  \"issues\": [\n    {\n      \"code\": \"INAPPROPRIATE_PROTOCOL_SELECTION\",\n      \"description\": \"Agent 2 included the low‑dose CT lung‑cancer screening protocol (CT_CHEST_LOW_DOSE_SCREENING) as a potential option, but this protocol does not evaluate pulmonary embolism and is unsuitable for the patient’s acute presentation.\"\n    },\n    {\n      \"code\": \"INCOMPLETE_LAB_METADATA\",\n      \"description\": \"Renal tool flagged missing BMI and absent timestamps for laboratory values, reducing the reliability of risk stratification.\"\n    },\n    {\n      \"code\": \"POTENTIAL_OVERHYDRATION\",\n      \"description\": \"Recommendation to aggressive pre‑hydration with isotonic saline may be unsafe given the patient’s hypotension (MAP 57 mmHg) and possible volume overload from CKD and heart disease. Fluid status must be assessed before any large‑volume hydration.\"\n    },\n    {\n      \"code\": \"HYPERKALAEMIA_NOT_ADDRESSED_PRIOR_TO_CONTRAST\",\n      \"description\": \"Critical hyperkalemia (K⁺ 5.8 mmol/L) must be corrected before any iodinated contrast administration; the current recommendations mention prioritization but do not specify concrete management steps.\"\n    },\n    {\n      \"code\": \"RENAL_RISK_UNDEREMPHASIZED\",\n      \"description\": \"eGFR 22 mL/min/1.73 m² places the patient at high risk for contrast‑induced nephropathy; the protocol suggestions lack explicit post‑contrast renal monitoring and use of iso‑osmolar contrast agents.\"\n    },\n    {\n      \"code\": \"ALTERNATIVE_MODALITY_NOT_EVALUATED\",\n      \"description\": \"Potential use of non‑contrast MR pulmonary angiography or nuclear medicine ventilation‑perfusion scan availability was not discussed, although these could be safer alternatives.\"\n    }\n  ],\n  \"recommendations\": [\n    {\n      \"action\": \"Imaging modality selection\",\n      \"detail\": \"Prioritize a ventilation‑perfusion (V/Q) scan as the first‑line test for suspected PE given severe CKD and hemodynamic instability. If V/Q is unavailable or non‑diagnostic, proceed to bedside transthoracic echocardiography to assess right‑heart strain.\"\n    },\n    {\n      \"action\": \"Exclude inappropriate protocol\",\n      \"detail\": \"Remove the low‑dose CT lung‑cancer screening protocol from consideration for this acute PE work‑up.\"\n    },\n    {\n      \"action\": \"Hyperkalemia management\",\n      \"detail\": \"Initiate urgent potassium‑lowering therapy (e.g., IV calcium gluconate, insulin‑glucose, nebulized albuterol, sodium polystyrene sulfonate) and re‑check serum K⁺ before any contrast study.\"\n    },\n    {\n      \"action\": \"Fluid assessment before hydration\",\n      \"detail\": \"Perform bedside assessment of volume status (e.g., ultrasound IVC, bedside echo, physical exam). If the patient is hypovolemic, give cautious isotonic saline (e.g., 250 mL bolus) with close hemodynamic monitoring; avoid aggressive large‑volume hydration in the setting of hypotension or possible heart failure.\"\n    },\n    {\n      \"action\": \"Contrast‑enhanced CT considerations\",\n      \"detail\": \"If CTPA becomes unavoidable, use iso‑osmolar, low‑iodine‑concentration contrast (e.g., iodixanol) at the minimal effective volume (≈80 mL). Apply a pre‑ and post‑procedure renal protection protocol: N‑acetylcysteine or sodium bicarbonate infusion, strict fluid balance, and repeat serum creatinine at 24‑48 h.\"\n    },\n    {\n      \"action\": \"Post‑contrast renal monitoring\",\n      \"detail\": \"Schedule serum creatinine and eGFR checks at 24 h and 48 h after contrast exposure; have nephrology consultation ready if renal function deteriorates.\"\n    },\n    {\n      \"action\": \"Data completeness improvement\",\n      \"detail\": \"Record patient BMI and include timestamps for all laboratory values in the EMR to improve future renal tool accuracy.\"\n    },\n    {\n      \"action\": \"Alternative non‑iodinated imaging\",\n      \"detail\": \"Evaluate the feasibility of a non‑contrast MR pulmonary angiography or a nuclear medicine V/Q scan (if available) as alternatives to iodinated contrast.\"\n    },\n    {\n      \"action\": \"Documentation\",\n      \"detail\": \"Document the rationale for selecting or rejecting each imaging protocol in the radiology order set, explicitly noting renal risk, hemodynamic status, and hyperkalemia management.\"\n    }\n  ],\n  \"confidence\": 0.86\n}",
  "hallucination_analysis": {
    "statement_assessments": [],
    "counts": {
      "supported": 0,
      "inferred": 0,
      "domain_safe": 0,
      "unverified": 0,
      "contradicted": 0
    },
    "hallucination_score": 0.0,
    "recommendation": {
      "force_revision": false,
      "confidence_reduction": 0.0
    },
    "knowledge_base_summary": {
      "numbers": {
        "subject_id": 30045678.0,
        "hadm_id": 45678912.0,
        "stay_id": 55661234.0,
        "age": 72.0,
        "hospital_expire_flag": 0.0,
        "los_hospital_days": 5.1,
        "los_icu_days": 4.6,
        "creatinine_mg_dl": 3.2,
        "bun_mg_dl": 65.0,
        "glucose_mg_dl": 180.0,
        "hemoglobin_g_dl": 9.5,
        "hematocrit_pct": 28.2,
        "platelet_count": 198.0,
        "wbc_count": 14.7,
        "sodium_meq_l": 134.0,
        "potassium_mmol_l": 5.8,
        "chloride_meq_l": 102.0,
        "bicarbonate_meq_l": 18.0,
        "egfr_ckd_epi": 22.0,
        "ckd_stage": 4.0,
        "bun_creatinine_ratio": 20.3,
        "heart_rate_bpm": 102.0,
        "systolic_bp_mmhg": 86.0,
        "diastolic_bp_mmhg": 42.0,
        "map_mmhg": 57.0,
        "pulse_pressure_mmhg": 44.0,
        "temperature_f": 100.2,
        "spo2_pct": 92.0,
        "respiratory_rate": 26.0,
        "data_completeness_pct": 0.91
      },
      "raw_strings_sample": [
        "18.0",
        "100.2",
        "86",
        "57.0",
        "102.0",
        "55661234",
        "3.2",
        "30045678",
        "20.3",
        "72"
      ]
    }
  },
  "feedback": {
    "issues": [
      {
        "code": "INAPPROPRIATE_PROTOCOL_SELECTION",
        "description": "Agent 2 included the low‑dose CT lung‑cancer screening protocol (CT_CHEST_LOW_DOSE_SCREENING) as a potential option, but this protocol does not evaluate pulmonary embolism and is unsuitable for the patient’s acute presentation."
      },
      {
        "code": "INCOMPLETE_LAB_METADATA",
        "description": "Renal tool flagged missing BMI and absent timestamps for laboratory values, reducing the reliability of risk stratification."
      },
      {
        "code": "POTENTIAL_OVERHYDRATION",
        "description": "Recommendation to aggressive pre‑hydration with isotonic saline may be unsafe given the patient’s hypotension (MAP 57 mmHg) and possible volume overload from CKD and heart disease. Fluid status must be assessed before any large‑volume hydration."
      },
      {
        "code": "HYPERKALAEMIA_NOT_ADDRESSED_PRIOR_TO_CONTRAST",
        "description": "Critical hyperkalemia (K⁺ 5.8 mmol/L) must be corrected before any iodinated contrast administration; the current recommendations mention prioritization but do not specify concrete management steps."
      },
      {
        "code": "RENAL_RISK_UNDEREMPHASIZED",
        "description": "eGFR 22 mL/min/1.73 m² places the patient at high risk for contrast‑induced nephropathy; the protocol suggestions lack explicit post‑contrast renal monitoring and use of iso‑osmolar contrast agents."
      },
      {
        "code": "ALTERNATIVE_MODALITY_NOT_EVALUATED",
        "description": "Potential use of non‑contrast MR pulmonary angiography or nuclear medicine ventilation‑perfusion scan availability was not discussed, although these could be safer alternatives."
      }
    ],
    "recommendations": [
      {
        "action": "Imaging modality selection",
        "detail": "Prioritize a ventilation‑perfusion (V/Q) scan as the first‑line test for suspected PE given severe CKD and hemodynamic instability. If V/Q is unavailable or non‑diagnostic, proceed to bedside transthoracic echocardiography to assess right‑heart strain."
      },
      {
        "action": "Exclude inappropriate protocol",
        "detail": "Remove the low‑dose CT lung‑cancer screening protocol from consideration for this acute PE work‑up."
      },
      {
        "action": "Hyperkalemia management",
        "detail": "Initiate urgent potassium‑lowering therapy (e.g., IV calcium gluconate, insulin‑glucose, nebulized albuterol, sodium polystyrene sulfonate) and re‑check serum K⁺ before any contrast study."
      },
      {
        "action": "Fluid assessment before hydration",
        "detail": "Perform bedside assessment of volume status (e.g., ultrasound IVC, bedside echo, physical exam). If the patient is hypovolemic, give cautious isotonic saline (e.g., 250 mL bolus) with close hemodynamic monitoring; avoid aggressive large‑volume hydration in the setting of hypotension or possible heart failure."
      },
      {
        "action": "Contrast‑enhanced CT considerations",
        "detail": "If CTPA becomes unavoidable, use iso‑osmolar, low‑iodine‑concentration contrast (e.g., iodixanol) at the minimal effective volume (≈80 mL). Apply a pre‑ and post‑procedure renal protection protocol: N‑acetylcysteine or sodium bicarbonate infusion, strict fluid balance, and repeat serum creatinine at 24‑48 h."
      },
      {
        "action": "Post‑contrast renal monitoring",
        "detail": "Schedule serum creatinine and eGFR checks at 24 h and 48 h after contrast exposure; have nephrology consultation ready if renal function deteriorates."
      },
      {
        "action": "Data completeness improvement",
        "detail": "Record patient BMI and include timestamps for all laboratory values in the EMR to improve future renal tool accuracy."
      },
      {
        "action": "Alternative non‑iodinated imaging",
        "detail": "Evaluate the feasibility of a non‑contrast MR pulmonary angiography or a nuclear medicine V/Q scan (if available) as alternatives to iodinated contrast."
      },
      {
        "action": "Documentation",
        "detail": "Document the rationale for selecting or rejecting each imaging protocol in the radiology order set, explicitly noting renal risk, hemodynamic status, and hyperkalemia management."
      }
    ],
    "confidence": 0.86
  }
}